Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put our financial performance into perspective.

Receptos team
+ 0.82 (+0.72%)
Day High: 115.53 Day Low: 111.00 Volume: 166,600
2:38 PM ET on
Jan 30, 2015
Delayed at least 20 minutes.
Dec 22, 2014
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis MORE»
Nov 24, 2014
Receptos Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Underwritten Public Offering of Common Stock MORE»
Nov 6, 2014 at 2:15 PM ET
Nomura's Biotechnology Conference MORE»
Nov 4, 2014 at 8:00 AM ET
Receptos Third Quarter 2014 Earnings Call MORE»